Tesamorelin is an FDA-approved prescription drug (brand name Egrifta), cleared in 2010 on the strength of multiple Phase 3 double-blind, placebo-controlled randomized trials for a specific, narrow indication: reducing excess abdominal fat in people with HIV-associated lipodystrophy
For related guidance on GLP-1 medications and the conception process more broadly, GLP-1 Medications and Fertility covers the current research in detail
For Vitamins (12 Tablets): Diluent (INS 460 (i)), Inositol, L-Ascorbic Acid, Diluent (INS 341 (ii)), DL-Alpha Tocopheryl Acetate, Niacinamide, Vehicle (INS 1521), Coating Agent (INS 464), Binder (INS 1201), Disintegrant (Sodium Starch Glycolate), Cholecalciferol, Glidant (INS 553 (iii)), Antisticking Agent (INS 470 (iii)), Retinyl Acetate, Calcium Pantothenate, Colour (Titanium dioxide coated mica pearlescent pigments and iron oxide), Anticaking Agent (Magnesium Aluminometasilicate), Pyridoxine Hydrochloride, Thiamine Mononitrate, Coating Agent (INS 462), Colours (INS 110), N-Phenyl-L-Glutamic Acid, Colour (INS 100), D-Biotin, Methylcobalamin, Beta Sitosterol
Contact your Optum Rx representative or complete our online form
